Rachel Gallagher

Company: 4:59 NewCo, a 5AM Ventures Company

Job title: Scientist

Seminars:

Panel Discussion: Deliberating the Benefits & Challenges of Current Preclinical Models to Move Towards Translational Success 11:30 am

Increasing the relevance and accessibility of animal models to ease and shorten the drug discovery process  How are rats and mice used in rare and genetic kidney diseases?  Assessing the ability to recapitulate more than one aspect of diseaseRead more

day: Conference Day Two Track A

Highlighting the Current Landscape for ARPKD Therapies When One Size Doesn’t Fit All Cystic Kidney Diseases 11:00 am

Illustrating the differences between ARPKD and ADPKD Interrogating translational models for ARPKD What are the current therapies and ongoing clinical trials for ARPKD?Read more

day: Conference Day One Track A AM